|
Online Database of Chemicals from Around the World | Search | Submit | Advertise | |
Home >> Chemical Listing >> Verdinexor>> Market Analysis Reports |
Market Analysis Reports of Verdinexor |
|
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2017 Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H2 2017 SUMMARY According to the recently published report 'Exportin 1 - Pipeline Review, H2 2017'; Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1 ... Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H1 2018 Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Pipeline Review, H1 2018 SUMMARY Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) - Exportin 1 (XPO1) or chromosomal maintenance 1 (CRM1) is a eukaryotic protein. It ... Hepatitis C: Drug Development Pipeline Study, H2 2018 With an estimated market value of over $30 billion by 2020, the Hepatitis C industry is considered as the rapidly growing healthcare markets. Hepatitis C affects around 200 million people worldwide and is associated with highest treatment failure rates. ... Global Veterinary Oncology Market By Animal Type (Canine and Feline) By Therapy (Chemotherapy, Radiology, Surgery, Immunotherapy and Others) By Cancer Type (Lymphoma, Mast Cell Cancer, Mammary & Squamous Cell Cancer and Others) By Region, Industry Analysis and Forecast, 2020 - 2026 ... Karyopharm to research, develop, and commercialize verdinexor (KPT-335) for the treatment ... Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Respiratory Syncytial ... North America Veterinary Oncology Market Size, Share & Trends Analysis Report By Animal (Canine, Feline), By Therapy (Radiotherapy, Surgery, Chemotherapy), By Cancer (Skin Cancer, Lymphoma), By Country, And Segment Forecasts, 2025 - 2030 ... , market, and support Laverdia-CA1 (verdinexor tablets) in the U.S. from Anivive Lifesciences ... Karyopharm Therapeutics Inc (KPTI) - Financial and Strategic SWOT Analysis Review ... pipeline drug candidates include selinexor, verdinexor, eltanexor, and KPT-9274. Karyopharm ... |